On 2 December 2025, at the Peoples' Friendship University of Russia named after Patrice Lumumba, Cochrane Russia, together with other members of the Cochrane Collaboration, the Editorial Board of the International Journal of Risk and Safety in Medicine, the Coalition for Rational and Safe Use of Medicines (CoRSUM), the Association of Clinical Pharmacologists of the Russian Federation, and with the participation of the World Health Organisation, held an extended Master class "Evidence-based clinical practice guidelines for multimorbidity: is there a paradigm shift?" to mark

December 6, the Cochrane School of Evidence-Based Medicine, QiQUM 2025, was held at Kazan State Medical University to celebrate the 10th anniversary of Cochrane Russia.The event was designed for young scientists and healthcare professionals, researchers, educators, decision-makers in healthcare and healthcare research, and all persons who want becoming involved in the Cochrane Collaboration's activies in Russia.The news was featured on the front pages of the Kazan State Medical University website:

Two new Cochrane reviews show strong and consistent evidence that HPV vaccines are effective in preventing cervical cancer and pre-cancerous changes, especially when given to young people before they are exposed to the virus. Girls vaccinated before the age of 16 were found to be 80% less likely to develop cervical cancer. The reviews also confirm that HPV vaccines are only likely to cause minor, transient side effects such as a sore arm. The reviews were supported by the National Institute for Health and Care Research (NIHR). 

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity.The reviews, which examine the effects of three weight loss drugs known as GLP-1 receptor agonists, have found that all three drugs result in clinically meaningful weight loss compared with placebo.

 Last week, Dr Karla Soares-Weiser was appointed as Cochrane’s Chief Executive Officer.

Cochrane’s Governing Board is pleased to announce the appointment of Dr Karla Soares-Weiser as the organization’s new Chief Executive Officer.

For over 30 years, the Cochrane Collaboration has set the standard for systematic reviews in health research. Our reviews have saved and improved countless lives across the world, providing trustworthy evidence to inform health decisions at all levels, from international policymakers to individual patients.We now want to take evidence synthesis to the next level, creating a more dynamic, open and equitable system so that decision-makers always have the latest evidence at their fingertips.

A new tool to identify problematic trials is now available, enabling researchers to check whether studies are trustworthy before including them in systematic reviews. What is INSPECT-SR?The INSPECT-SR tool (INveStigating ProblEmatic Clinical Trials in Systematic Reviews) was created by an international group of researchers to address the risks posed by untrustworthy randomized controlled trials (RCTs).

A systematic review for the Royal College of AnaesthetistsWith the UK’s National Health Service facing critical workforce shortages, the Royal College of Anaesthetists (RCoA) needed to better understand the role that non-physician providers of anaesthesia, such as anaesthesia associates (AAs), could play in delivering safe, effective care.

Updated evidence shows that tailored exercise programs, vitamin D supplements and dairy-rich diets can help reduce falls in care homes.Falls remain one of the most serious health risks facing older people living in residential aged care around the world.